Adds biologics development capabilities, expertise and scale from discovery through GMP manufacturing ALBANY, N.Y.–(BUSINESS WIRE)–September 2, 2021– Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today announced it has completed the transaction to acquire LakePharma Inc., a privately held biologics drug discovery, clinical research, development and manufacturing organization with operations in California, […]
Home »
Curia to Expand U.S. Commercial Manufacturing Capability
ALBANY, N.Y.–(BUSINESS WIRE)–August 19, 2021– Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today announced plans to expand its commercial manufacturing capacity at its Rensselaer, New York facility. The increased capability to flexibly manufacture complex Active Pharmaceutical Ingredients (APIs) will further strengthen Curia’s ability to partner with customers, meeting small-scale to large-volume […]